Toronto, Ontario, Canada, June 18, 2002 --Ashbury Biologicals Inc., a Canadian leader in the development of ethical herbal drug products and nutritional supplements announces the initiation of a strategic partnership with SSP Co. Ltd. of Tokyo, Japan. SSP is a research-based manufacturer of Over The Counter (OTC) self-medications, dietary supplements, personal care products, and prescription pharmaceuticals. They are the third largest OTC pharmaceutical marketer in Japan. This alliance will lead to the introduction of products that have been successful in the Japanese market, to North America and the relationship will also lead to new product development.
“The SSP alliance and our US launch plans are vitally important as the next stage of our commitment to creating a world class health care company with a broad range of science-based herbal and nutritional products as well as prescription pharmaceuticals,” commented Ashbury’s President, Peter Pekos. “Given SSP’s resources, and our common commitment to science-based health care, it is an ideal combination propelling us towards our goal to be a significant player in the North American market.”
Ashbury Biologicals, founded in 1991, develops and markets innovative, highly characterized plant based therapies as OTC consumer products for the North American marketplace. Working with its sister company, Dalton Chemical Laboratories, (www.dalton.com) the companies use powerful synergies, expertise in research and development as well as analytical chemistry to produce innovative and superior products.